Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
434 questions in 75 reviews · Metabolic and Endocrine Disorders
current versionsNo studies 434 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Obesity Class II vs Normal Weight or Non‐Obese  · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class III vs Normal BMI, Non‐obese, or BMI < 40 OutcomesTime frame of absolute effects · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class III vs Normal BMI, Non‐obese, or BMI < 40 Severe COVID · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class III vs Normal BMI, Non‐obese, or BMI < 40 .Pneumonia · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class III vs Normal BMI, Non‐obese, or BMI < 40 Â · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity (Unclassified) vs Normal Weight or Non‐Obese OutcomesTime frame of absolute effects · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity (Unclassified) vs Normal Weight or Non‐Obese  · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Every 5 units (kg/m2) increase in BMI vs N/A OutcomesTime frame of absolute effects · Adults with COVID Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Every 5 units (kg/m2) increase in BMI vs N/A ICU admission · Adults with COVID Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Every 5 units (kg/m2) increase in BMI vs N/A Pneumonia · Adults with COVID Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Every 5 units (kg/m2) increase in BMI vs N/A Â · Adults with COVID Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class I vs Normal Weight or Non‐Obese Pneumonia  · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class I vs Normal Weight or Non‐Obese  · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Obesity Class II vs Normal Weight or Non‐Obese OutcomesTime frame of absolute effects · Adults with COVID‐19 Obesity as an independent risk factor for COVID‐19 severity and mortality (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Potency/bioactivity parameters of human insulin · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetic ketoacidosis · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hypoglycaemic episodes · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR HbA1c · healthy physicians Thermal stability and storage of human insulin (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · children and adolescents with obesity Surgery for the treatment of obesity in children and adolescents (2022) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · children and adolescents with obesity Surgery for the treatment of obesity in children and adolescents (2022) · Cochrane | no estimate extracted | NR | No studies |
Recombinant human thyrotropin‐aided radioiodine vs radioiodine Costs Recombinant human thyrotropin (rhTSH)‐aided radioiodine treatment for non‐toxic multinodular goitre (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: insulin detemir vs insulin glargine Health‐related quality of life (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetes‐related morbidity · individuals without known diabetes mellitus but at high risk for the condition Screening for type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of type 2 diabetes · individuals without known diabetes mellitus but at high risk for the condition Screening for type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · individuals without known diabetes mellitus but at high risk for the condition Screening for type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · individuals without known diabetes mellitus but at high risk for the condition Screening for type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · individuals without known diabetes mellitus but at high risk for the condition Screening for type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Insulin detemir vs NPH insulin Socioeconomic effects (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2… (2020) · Cochrane | no estimate extracted | NR | No studies |
Insulin glargine vs NPH insulin Socioeconomic effects (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Basal calcitonin Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Subgroup analysis Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cut‐off value Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Gender (basal calcitonin) Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules (2020) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive parathyroidectomy vs bilateral neck exploration Length of hospital stay Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and… (2020) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs Diabetes‐related complications Resveratrol for adults with type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs Health‐related quality of life Resveratrol for adults with type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs Socioeconomic effects Resveratrol for adults with type 2 diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs vitamin D All‐cause mortality Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs vitamin D Health‐related quality of life Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs vitamin D Socioeconomic effects Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs calcium All‐cause mortality Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs calcium Health‐related quality of life Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Vitamin D plus calcium vs calcium Socioeconomic effects Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events (number) Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Non‐nutritive sweeteners for diabetes mellitus (2020) · Cochrane | no estimate extracted | NR | No studies |